Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness
Clinical trial NCT04327661 · COMPLETED
Trial details
- NCT number
- NCT04327661
- Sponsor
- Vanda Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2023-04-01
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.